Nicholas Brodszki
11 – 20 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil®in 9-15-Year-Old Girls.
(
- Contribution to journal › Article
-
Mark
Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: Evidence for increased levels of serum bactericidal antibodies.
(
- Contribution to journal › Article
-
Mark
Novel Genetic Mutations in the First Swedish Patient with Purine Nucleoside Phosphorylase Deficiency and Clinical Outcome After Hematopoietic Stem Cell Transplantation with HLA-Matched Unrelated Donor.
(
- Contribution to journal › Article
- 2014
-
Mark
Primary immunodeficiency in infection-prone children in southern Sweden: occurrence, clinical characteristics and immunological findings.
(
- Contribution to journal › Article
-
Mark
Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots.
(
- Contribution to journal › Article
-
Mark
Immunologic findings in young children with early onset of acute otitis media.
(
- Contribution to journal › Article
- 2012
-
Mark
Immunologic aberrations in children with early onset of acute otitis media
2012) European Society of Pediatric Otorhinolaryngology, 2012(
- Contribution to conference › Abstract
- 2011
-
Mark
A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax
(
- Contribution to journal › Article
- 2008
-
Mark
Swedish guidelines for the assessment, diagnosis and management of 6 primary immunodeficiency states: CVID, IgG subclass deficiency, IgA deficiency, XLA, SCID and CGD
2008) 13th European-Soc-for-Immunodeficiencies/10th Int-Patient-Org-for-Primary-Immunodeficiencies/8th Int-Nursing-Group-for-Immunodeficiencies Meeting In Clinical and Experimental Immunology 154. p.140-141(
- Contribution to journal › Published meeting abstract